Physicians, nurse practitioners, or physician assistants prescribed medication to patients with OUD, while intervention ...

Merck & Co., a global pharmaceutical leader, focuses on oncology, immunology, and vaccines. Click here to check out my ...

As 2024 comes to an end, it is crucial to take a look at some of the major medical advancements that happened this year. 2024 ...

Nancy Bayer is Steve’s wife, and she said she’s known Lula for nearly 60 years. And on Friday, Nancy talked about what ...

With Eylea biosimilar competition creeping in and Roche’s Vabsymo jockeying for market share in key indications, Regeneron is ...

An investigation conducted by Canada’s National Observer finds that Bayer colluded with Canadian regulators to obstruct a ...

The potential for TL1A-targeting duvakitug to impact unmet needs of patients with ulcerative colitis (UC) and Crohn’s disease (CD), and to provide anti-fibrotic effects for a host of other diseases, ...

The European Commission opened a formal investigation over concerns foreign actors used the hugely popular video platform to interfere in Romanian presidential elections.

Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA ...

The Phase III win could help Regeneron and Bayer expand into retinal vein occlusion, a move that the partners need to help ...

Regeneron (NASDAQ:REGN) announced Tuesday that Eylea HD, the high-dose version of its blockbuster eye care medication Eylea ...

Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for ...